SPC350

Icosapentetýl

  • Status:
    Veitt
  • Application date:
    15.9.2021
  • Application published:
    15.10.2021
  • Grant published:
    15.2.2025
  • Max expiry date:
    14.6.2035
  • Medicine name:
    Vazkepa
  • Medicine for children:
    No

Timeline

Today
15.9.2021Application
15.10.2021Publication
15.2.2025Registration
14.6.2035Expires

Marketing license

  • IS authorization number:
    EU/1/20/1524/001-002
  • Date:
    30.3.2021
  • Foreign authorization number:
    EU/1/20/1524
  • Date:
    26.3.2021

Owner

  • Name:
    Amarin Pharmaceuticals Ireland Limited
  • Address:
    2 Pembroke House Upper Pembroke Street 28-32, Dublin 2 IE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 05.01.2025

Upload documents